Daiichi Sankyo Co., Ltd.

  • Market Cap: Large Cap
  • Industry: Pharmaceuticals & Biotechnology
  • ISIN: JP3475350009
JPY
2,869.00
2842.25 (10625.23%)
  • Price Points
  • Score
  • Mojo Parameters
  • Total Return
  • News and Corporate Actions
  • Key factors
  • Shareholding
  • Financials
  • CompanyCV
stock-summaryPrice Point
High/Low

1Day

52 Week

Valuation
Technical
Day's Volume

CASH

13.71 M

Shareholding (Sep 2025)

FII

0.00%

Held by 4 FIIs

DII

100.0%

Held by 0 DIIs

Promoter

0.00%

iScoreScore
Click here to find our call on this stock
Strong Sell
Sell
Hold
Buy
Strong Buy

MarketsMojo — Loved in India, Now Global

The power of Mojo is now in 29 countries. Explore global equities with the same cutting-edge features you love.

Dashboard

1

Company has a low Debt to Equity ratio (avg) at times

 
2

Healthy long term growth as Net Sales has grown by an annual rate of 13.95% and Operating profit at 16.92%

 
3

Flat results in Jun 25

4

With ROE of 18.22%, it has a attractive valuation with a 4.17 Price to Book Value

5

Majority shareholders : Non Institution

 
6

Consistent Underperformance against the benchmark over the last 3 years

stock-summaryMojo Parameters

Mojo Parameters

Stock DNA

stock-summary
Industry

Pharmaceuticals & Biotechnology

stock-summary
Market cap

JPY 6,268,406 Million (Large Cap)

stock-summary
P/E

23.00

stock-summary
Industry P/E

NA

stock-summary
Dividend Yield

0.00%

stock-summary
Debt Equity

-0.21

stock-summary
Return on Equity

16.94%

stock-summary
Price to Book

3.79

Revenue and Profits:
Net Sales:
474,597 Million
(Quarterly Results - Jun 2025)
Net Profit:
85,500 Million
stock-summaryTotal Returns
Total Returns (Price + Dividend) stock-summary
TimePeriod
Price Return
Dividend Return
Total Return
3 Months
3178.86%
0%
3178.86%
6 Months
3983.4%
0%
3983.4%
1 Year
4527.42%
0%
4527.42%
2 Years
6656.95%
0%
6656.95%
3 Years
12428.38%
0%
12428.38%
4 Years
12202.74%
0%
12202.74%
5 Years
14650.64%
0%
14650.64%

Daiichi Sankyo Co., Ltd. for the last several years.

Risk Adjusted Returns v/s stock-summary
stock-summaryNews & Corporate Actions

News

Icon
No Recent News for the Company

Announcements stock-summary

Icon
No announcement available

Corporate Actions stock-summary

Icon
No corporate action available
stock-summaryKey Factors

Quality key factors stock-summary

Factor
Value
Sales Growth (5y)
13.95%
EBIT Growth (5y)
16.92%
EBIT to Interest (avg)
14.00
Debt to EBITDA (avg)
0
Net Debt to Equity (avg)
-0.33
Sales to Capital Employed (avg)
0.96
Tax Ratio
16.91%
Dividend Payout Ratio
38.47%
Pledged Shares
0
Institutional Holding
0.00%
ROCE (avg)
15.44%
ROE (avg)
9.72%

Valuation key factors

Factor
Value
P/E Ratio
23
Industry P/E
Price to Book Value
4.17
EV to EBIT
20.55
EV to EBITDA
16.76
EV to Capital Employed
5.74
EV to Sales
3.30
PEG Ratio
0.46
Dividend Yield
NA
ROCE (Latest)
27.96%
ROE (Latest)
18.22%

Technicals key factors

Indicator
Weekly
Monthly
MACD
Bearish
Bearish
RSI
No Signal
Bullish
Bollinger Bands
Mildly Bearish
Mildly Bearish
Moving Averages
Bearish (Daily)
KST
Bearish
Bearish
Dow Theory
No Trend
No Trend
OBV
No Trend
No Trend
stock-summary Technical Indicator Scale: Bearish, Mildly Bearish, Sideways, Mildly Bullish, Bullish  Turned 
stock-summaryShareholding
Shareholding Snapshot : Sep 2025stock-summary
Shareholding Compare (%holding) stock-summary
Majority shareholders

Foreign Institutions

Domestic Funds

Held in 0 Schemes (0%)

Foreign Institutions

Held by 4 Foreign Institutions (0.0%)

Strategic Entities with highest holding

Highest Public shareholder

stock-summaryFinancial
[
  {
    "link": "quarterly",
    "btn_text": "All Quarterly Results",
    "header": "Quarterly Results Snapshot (Consolidated) - Jun'25 - YoY",
    "rhs": [
      {
        "prefix": "Net Sales ",
        "suffix": "YoY Growth in quarter ended Jun 2025 is 8.81% vs 24.32% in Jun 2024",
        "dir": -1
      },
      {
        "prefix": "Consolidated Net Profit ",
        "suffix": "YoY Growth in quarter ended Jun 2025 is 0.14% vs 49.76% in Jun 2024",
        "dir": -1
      }
    ],
    "table": {
      "header": [
        "Jun'25",
        "Jun'24",
        "Change(%)"
      ],
      "body": [
        {
          "field": "Net Sales",
          "val1": "474,597.00",
          "val2": "436,175.00",
          "chgp": "8.81%",
          "chgp_class": "positive"
        },
        {
          "field": "Operating Profit (PBDIT) excl Other Income",
          "val1": "113,754.00",
          "val2": "81,912.00",
          "chgp": "38.87%",
          "chgp_class": "positive"
        },
        {
          "field": "Interest",
          "val1": "1,419.00",
          "val2": "1,974.00",
          "chgp": "-28.12%",
          "chgp_class": "positive"
        },
        {
          "field": "Exceptional Items",
          "val1": "0.00",
          "val2": "0.00",
          "chgp": "",
          "chgp_class": "neutral"
        },
        {
          "field": "Consolidate Net Profit",
          "val1": "85,500.00",
          "val2": "85,383.00",
          "chgp": "0.14%",
          "chgp_class": "positive"
        },
        {
          "field": "Operating Profit Margin (Excl OI)",
          "val1": "202.20%",
          "val2": "149.70%",
          "chgp": "5.25%",
          "chgp_class": "positive"
        }
      ]
    }
  },
  {
    "link": "annual",
    "btn_text": "All Annual Results",
    "header": "Annual Results Snapshot (Consolidated) - Mar'25",
    "rhs": [
      {
        "prefix": "Net Sales ",
        "suffix": "YoY Growth in year ended Mar 2025 is 17.77% vs 25.28% in Mar 2024",
        "dir": -1
      },
      {
        "prefix": "Consolidated Net Profit ",
        "suffix": "YoY Growth in year ended Mar 2025 is 47.13% vs 84.10% in Mar 2024",
        "dir": -1
      }
    ],
    "table": {
      "header": [
        "Mar'25",
        "Mar'24",
        "Change(%)"
      ],
      "body": [
        {
          "field": "Net Sales",
          "val1": "1,886,256.00",
          "val2": "1,601,688.00",
          "chgp": "17.77%",
          "chgp_class": "positive"
        },
        {
          "field": "Operating Profit (PBDIT) excl Other Income",
          "val1": "377,392.00",
          "val2": "250,235.00",
          "chgp": "50.82%",
          "chgp_class": "positive"
        },
        {
          "field": "Interest",
          "val1": "3,401.00",
          "val2": "4,195.00",
          "chgp": "-18.93%",
          "chgp_class": "positive"
        },
        {
          "field": "Exceptional Items",
          "val1": "-1,490.00",
          "val2": "5,062.00",
          "chgp": "-129.44%",
          "chgp_class": "negative"
        },
        {
          "field": "Consolidate Net Profit",
          "val1": "295,756.00",
          "val2": "201,016.00",
          "chgp": "47.13%",
          "chgp_class": "positive"
        },
        {
          "field": "Operating Profit Margin (Excl OI)",
          "val1": "163.70%",
          "val2": "116.10%",
          "chgp": "4.76%",
          "chgp_class": "positive"
        }
      ]
    }
  }
]

Quarterly Results Snapshot (Consolidated) - Jun'25 - YoYstock-summary

Jun'25
Jun'24
Change(%)
Net Sales
474,597.00
436,175.00
8.81%
Operating Profit (PBDIT) excl Other Income
113,754.00
81,912.00
38.87%
Interest
1,419.00
1,974.00
-28.12%
Exceptional Items
0.00
0.00
Consolidate Net Profit
85,500.00
85,383.00
0.14%
Operating Profit Margin (Excl OI)
202.20%
149.70%
5.25%
USD in Million.
Direction Arrows
Net Sales

YoY Growth in quarter ended Jun 2025 is 8.81% vs 24.32% in Jun 2024

Direction Arrows
Consolidated Net Profit

YoY Growth in quarter ended Jun 2025 is 0.14% vs 49.76% in Jun 2024

Annual Results Snapshot (Consolidated) - Mar'25stock-summary

Mar'25
Mar'24
Change(%)
Net Sales
1,886,256.00
1,601,688.00
17.77%
Operating Profit (PBDIT) excl Other Income
377,392.00
250,235.00
50.82%
Interest
3,401.00
4,195.00
-18.93%
Exceptional Items
-1,490.00
5,062.00
-129.44%
Consolidate Net Profit
295,756.00
201,016.00
47.13%
Operating Profit Margin (Excl OI)
163.70%
116.10%
4.76%
USD in Million.
Direction Arrows
Net Sales

YoY Growth in year ended Mar 2025 is 17.77% vs 25.28% in Mar 2024

Direction Arrows
Consolidated Net Profit

YoY Growth in year ended Mar 2025 is 47.13% vs 84.10% in Mar 2024

stock-summaryCompany CV
About Daiichi Sankyo Co., Ltd. stock-summary
stock-summary
Daiichi Sankyo Co., Ltd.
Pharmaceuticals & Biotechnology
No Details Available.
Company Coordinates stock-summary
Icon
No Company Details Available